You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for New Drug Application (NDA): 019922


✉ Email this page to a colleague

« Back to Dashboard


NDA 019922 describes CORLOPAM, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the CORLOPAM profile page.

The generic ingredient in CORLOPAM is fenoldopam mesylate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fenoldopam mesylate profile page.
Summary for 019922
Tradename:CORLOPAM
Applicant:Hospira
Ingredient:fenoldopam mesylate
Patents:0
Pharmacology for NDA: 019922
Mechanism of ActionDopamine Agonists
Medical Subject Heading (MeSH) Categories for 019922
Suppliers and Packaging for NDA: 019922
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CORLOPAM fenoldopam mesylate INJECTABLE;INJECTION 019922 NDA Hospira, Inc. 0409-3373 0409-3373-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-3373-01) / 1 mL in 1 VIAL, SINGLE-DOSE
CORLOPAM fenoldopam mesylate INJECTABLE;INJECTION 019922 NDA Hospira, Inc. 0409-3373 0409-3373-02 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-3373-02) / 2 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Sep 23, 1997TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.